311 related articles for article (PubMed ID: 26421752)
1. Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA.
Parren PW; Burton DR; Bradbury A; Huston JS; Carter PJ; Veldman T; Chester KA; Larrick JW; Alfenito MR; Scott JK; Weiner LM; Adams GP; Reichert JM
MAbs; 2015; 7(6):981-8. PubMed ID: 26421752
[TBL] [Abstract][Full Text] [Related]
2. Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.
Pauthner M; Yeung J; Ullman C; Bakker J; Wurch T; Reichert JM; Lund-Johansen F; Bradbury AR; Carter PJ; Melis JP
MAbs; 2016; 8(3):617-52. PubMed ID: 26909869
[TBL] [Abstract][Full Text] [Related]
3. Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.
Larrick JW; Alfenito MR; Scott JK; Parren PW; Burton DR; Bradbury AR; Lemere CA; Messer A; Huston JS; Carter PJ; Veldman T; Chester KA; Schuurman J; Adams GP; Reichert JM
MAbs; 2016; 8(8):1425-1434. PubMed ID: 27557809
[TBL] [Abstract][Full Text] [Related]
4. IBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CA.
Klöhn PC; Wuellner U; Zizlsperger N; Zhou Y; Tavares D; Berger S; Zettlitz KA; Proetzel G; Yong M; Begent RH; Reichert JM
MAbs; 2013; 5(2):178-201. PubMed ID: 23575266
[TBL] [Abstract][Full Text] [Related]
5. IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA.
Marquardt J; Begent RH; Chester K; Huston JS; Bradbury A; Scott JK; Thorpe PE; Veldman T; Reichert JM; Weiner LM
MAbs; 2012; 4(6):648-52. PubMed ID: 23007482
[TBL] [Abstract][Full Text] [Related]
6. IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.
Nilvebrant J; Dunlop DC; Sircar A; Wurch T; Falkowska E; Reichert JM; Helguera G; Piccione EC; Brack S; Berger S
MAbs; 2012; 4(2):153-81. PubMed ID: 22453091
[TBL] [Abstract][Full Text] [Related]
7. IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA.
Arnett SO; Teillaud JL; Wurch T; Reichert JM; Dunlop C; Huber M
MAbs; 2011; 3(2):133-52. PubMed ID: 21304271
[TBL] [Abstract][Full Text] [Related]
8. Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014.
Larrick JW; Parren P; Huston JS; Plückthun A; Bradbury A; Tomlinson IM; Chester KA; Burton DR; Adams GP; Weiner LM; Scott JK; Alfenito MR; Veldman T; Reichert JM
MAbs; 2014; 6(5):1115-23. PubMed ID: 25517297
[TBL] [Abstract][Full Text] [Related]
9. Current strategies in antibody engineering: Fc engineering and pH-dependent antigen binding, bispecific antibodies and antibody drug conjugates.
Vincent KJ; Zurini M
Biotechnol J; 2012 Dec; 7(12):1444-50. PubMed ID: 23125076
[TBL] [Abstract][Full Text] [Related]
10. Bispecific antibodies for viral immunotherapy.
Nyakatura EK; Soare AY; Lai JR
Hum Vaccin Immunother; 2017 Apr; 13(4):836-842. PubMed ID: 27786606
[TBL] [Abstract][Full Text] [Related]
11. The coming of age of engineered multivalent antibodies.
Nuñez-Prado N; Compte M; Harwood S; Álvarez-Méndez A; Lykkemark S; Sanz L; Álvarez-Vallina L
Drug Discov Today; 2015 May; 20(5):588-94. PubMed ID: 25757598
[TBL] [Abstract][Full Text] [Related]
12. The current status and prospects of antibody engineering for therapeutic use: focus on glycoengineering technology.
Niwa R; Satoh M
J Pharm Sci; 2015 Mar; 104(3):930-41. PubMed ID: 25583555
[TBL] [Abstract][Full Text] [Related]
13. [Next Generation Antibody Therapeutics Using Bispecific Antibody Technology].
Igawa T
Yakugaku Zasshi; 2017; 137(7):831-836. PubMed ID: 28674296
[TBL] [Abstract][Full Text] [Related]
14. Next generation antibody drugs: pursuit of the 'high-hanging fruit'.
Carter PJ; Lazar GA
Nat Rev Drug Discov; 2018 Mar; 17(3):197-223. PubMed ID: 29192287
[TBL] [Abstract][Full Text] [Related]
15. Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.
Almagro JC; Gilliland GL; Breden F; Scott JK; Sok D; Pauthner M; Reichert JM; Helguera G; Andrabi R; Mabry R; Bléry M; Voss JE; Laurén J; Abuqayyas L; Barghorn S; Ben-Jacob E; Crowe JE; Huston JS; Johnston SA; Krauland E; Lund-Johansen F; Marasco WA; Parren PW; Xu KY
MAbs; 2014; 6(3):577-618. PubMed ID: 24589717
[TBL] [Abstract][Full Text] [Related]
16. Homogeneously modified immunoglobulin domains for therapeutic application.
Liu T; Du J; Luo X; Schultz PG; Wang F
Curr Opin Chem Biol; 2015 Oct; 28():66-74. PubMed ID: 26117722
[TBL] [Abstract][Full Text] [Related]
17. Engineering antibodies for therapy.
Presta LG
Curr Pharm Biotechnol; 2002 Sep; 3(3):237-56. PubMed ID: 12164480
[TBL] [Abstract][Full Text] [Related]
18. 7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.
Lugovskoy AA; Reichert JM; Beck A
MAbs; 2012; 4(2):134-52. PubMed ID: 22453093
[TBL] [Abstract][Full Text] [Related]
19. Advances in Antibody Design.
Tiller KE; Tessier PM
Annu Rev Biomed Eng; 2015; 17():191-216. PubMed ID: 26274600
[TBL] [Abstract][Full Text] [Related]
20. Precision medicine in clinical oncology: the journey from IgG antibody to IgE.
Fazekas-Singer J; Singer J; Jensen-Jarolim E
Curr Opin Allergy Clin Immunol; 2020 Jun; 20(3):282-289. PubMed ID: 32349107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
